CAPTRUST FINANCIAL ADVISORS - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 85 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$17,101
-15.7%
21,9240.0%0.00%
Q2 2023$20,280
-14.0%
21,924
+1.4%
0.00%
Q1 2023$23,568
+12.2%
21,622
+10.2%
0.00%
Q3 2022$21,000
+162.5%
19,622
+324.5%
0.00%
Q2 2022$8,000
-20.0%
4,6220.0%0.00%
Q1 2022$10,000
+150.0%
4,622
+391.7%
0.00%
Q4 2021$4,000
-20.0%
9400.0%0.00%
Q3 2021$5,000
+25.0%
9400.0%0.00%
Q2 2021$4,000
-20.0%
9400.0%0.00%
Q1 2021$5,0009400.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,054,864$8,597,0005.88%
NEA Management Company, LLC 9,880,999$80,530,0004.18%
Abingworth LLP 250,000$2,033,0002.13%
New Leaf Venture Partners, L.L.C. 127,041$1,035,0000.89%
Iguana Healthcare Management, LLC 200,000$1,630,0000.66%
Rock Springs Capital Management LP 765,001$6,235,0000.46%
QVT Financial LP 783,645$6,387,0000.44%
Opaleye Management Inc. 40,000$326,0000.22%
Rathbones Group PLC 450,525$3,672,0000.20%
Virtus ETF Advisers LLC 26,974$220,0000.16%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders